Terns Pharmaceuticals Inc (TERN)
R&D Expenses
$18.90M
Quarterly · Period ending: · USD
TERN R&D Expenses
Latest reported$18.90Mperiod ending
Latest reported$18.90Mperiod ending
TERN Quarterly R&D Expenses ($7.56M → $18.90M)
Quarterly R&D Expenses
High-resolution chart · PNG
TERN r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 18,899,000 | |
| 19,917,000 | |
| 20,353,000 | |
| 18,720,000 | |
| 18,004,000 | |
| 15,169,000 | |
| 18,352,000 | |
| 18,587,000 | |
| 17,459,000 | |
| 14,831,000 | |
| 14,151,000 | |
| 17,056,000 | |
| 10,658,000 | |
| 12,161,000 | |
| 8,662,000 | |
| 8,136,000 | |
| 9,462,000 | |
| 7,153,000 | |
| 5,961,000 | |
| 8,735,000 | |
| 7,770,000 | |
| 5,404,000 | |
| 7,611,000 | |
| 7,244,000 | |
| 7,556,000 |